| | | Four Winship trainees in hematology and medical oncology, radiation oncology, and surgery are recipients of this year's Nell W. and William Simpson Elkin Fellowship and Chester Rochfort Scholarship. The awards are given out annually to extraordinary physician-scientists enrolled in eligible Emory training programs and who have cancer-related career goals. Pictured: Elkin Fellows Deepthi Kodali, MBBS, and Lisa Sudmeier, MD, PhD, and Rochfort Scholars Jessica Keilson, MD, and Caitlin Taylor, MD, MS. | Read More |
| |
| | Precision medicine with multiple myeloma | "Precision medicine" is an anti-cancer treatment strategy in which doctors use genetic or other tests to identify vulnerabilities in an individual's cancer subtype. Winship multiple myeloma investigators, including Drs. Vikas Gupta, Jonathan Kaufman, and Larry Boise, are working to apply this strategy to using a promising drug called venetoclax.
| Read More | |
| | | | How promiscuous protein droplets regulate immune genes | New research from Eric Ortlund, PhD, Xu Liu, PhD, and colleagues sheds light on how an important regulator of the immune system switches its function, based on its orientation and local environment. The results were published this week in Proceedings of the National Academy of Sciences.
| Read More | |
|
| |
| |
| Below are four selected Winship publications out of 91 published over the past week: |
| |
|
| DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith KC, Weiss B, Yanik GA, Twist CJ, Irwin MS, Haas-Kogan DA, Park JR, Marachelian A, Matthay KK. Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2021:JCO2100703. PubMed PMID: 34270348. | View in PubMed |
| |
|
| Gooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece IK, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M. HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. Blood. 2021; 138(3):273-282. PubMed PMID: 34292325. | View in PubMed |
| |
|
| Zhu L, Chen Z, Zang H, Fan S, Gu J, Zhang G, Sun KD, Wang Q, He Y, Owonikoko TK, Ramalingam SS, Sun SY. Targeting c-Myc to overcome acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR tyrosine kinase inhibitor, osimertinib. Cancer Research. 2021; PubMed PMID: 34289988. | View in PubMed |
| |
|
| Sibold HC, Thomson MC, Hianik R, Abernethy ER, Campbell GP, Sumrall B, Dillmon M, Simmons J, Switchenko JM, Dixon MD, Pentz RD. Videos improve patient understanding of chemotherapy terminology in a rural setting. Cancer. 2021; PubMed PMID: 34289098. | View in PubMed |
| |
| |
| A selection of media stories and news coverage for Winship Cancer Institute. |
| |
| You are receiving Winship Roundup as a member or employee of Winship Cancer Institute. If you wish to unsubscribe, please email Winship Communications.
Emory Home |
Emory News Center |
Give to Emory |
Contact Emory Have a story for Winship Roundup? Submit your suggestion via email. © 2021 Winship Cancer Institute of Emory University |
1365 Clifton Rd. NE, Bldg. C, Atlanta, Georgia 30322 | |
|